Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure

European Journal of Preventive Cardiology

Volumn 22, Issue 2, 2015, Pages 249-262

  Bello, Vitantonio Di ^a   Carrubba, Salvatore La ^b   Antonini Canterin, Francesco ^b   Salvo, Giovanni Di ^b   Caso, Pio ^b   Canna, Giovanni La ^b   Erlicher, Andrea ^b   Badano, Luigi ^b   Romano, Maria Francesca ^c   Zito, Concetta ^b   Vriz, Olga ^b   Conte, Lorenzo ^a   Carerj, Scipione ^b  

^a UNIVERSITY OF PISA   (Italy)

^b SIEC   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Cardiovascular risk factors; echocardiography; electrocardiography; heart failure

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; CLINICAL TRIAL; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED;

AGED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84920944557     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487313508343     Document Type: Article

References (42)

1. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002 ; 106: 3068-3072
2. McMurray JV, McDonagh TA, Davie AP, et al. Should we screen for asymptomatic left ventricular dysfunction to prevent heart failure?. Eur Heart J. 1998 ; 19: 842-846
3. Hobbs FDR, Kenkre JE, Roalfe AK, et al. Impact of heart failure and left ventricular systolic dysfunction on quality of life. A cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J. 2002 ; 23: 1867-1876
4. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006 ; 355: 260-269
5. Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J. 1997 ; 133: 703-712
6. Carerj S, La Carrubba S, Antonini-Canterin F, et al. The incremental prognostic value of echocardiography in asymptomatic stage a heart failure. J Am Soc Echocardiogr. 2010 ; 23: 1025-1034
7. Mosterd A, Hoes AW, de Brune MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. Eur Heart J. 1999 ; 20: 447-455
8. Davies M, Hobbs F, Davis R, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001 ; 358: 439-444
9. Goldberg LR, Jessup M. Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation. 2006 ; 113: 2851-2860
10. Chou R, Arora B, Dana T, et al. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011 ; 155: 375-385
11. Auer R, Bauer DC, Marques-Vidal P, et al. Association of major and minor ECG abnormalities with coronary heart disease events. JAMA. 2012 ; 307: 1497-1505
12. Badheka AO, Patel N, Tuliani TA, et al. Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III. Am J Med. 2013 ; 126: 319-326
13. Quinones MA, Douglas PS, Foster E, et al. ACC/AH clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/ American College of Physicians - American Society of Internal Medicine Task Force on Clinical Competence (Committee on Echocardiography). J Am Coll Cardiol. 2003 ; 41: 687-670
14. Hunt SA, Abraham WT, Casey DE, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005 ; 46: e1 - e82
15. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. Circulation. 2009 ; 119: 1977-2016
16. McMurray JJV, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 ; 33: 1787-1847
17. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989 ; 2: 358-367
18. Wu CC, Yeh WT, Crow RS, et al. Comparison of electrocardiographic findings and associated risk factors between Taiwan Chinese and US White adults. Int J Cardiol. 2008 ; 128: 224-231
19. Macfarlane PW. Minnesota coding and the prevalence of ECG abnormalities. Heart. 2000 ; 84: 582-584
20. Kors JA, Crow RS, Hannan PJ, et al. Comparison of computerassigned Minnesota Codes with the visual standard method for new coronary heart disease events. Am J Epidemiol. 2000 ; 151: 790-797
21. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009 ; 22: 107-133
22. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992 ; 20: 1251-1260
23. Wachtell K, Bella JN, Liebson PR, et al. Impact of different partition values on the prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension. 2000 ; 35: 6-12
24. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998 ; 98: 2282-2289
25. Baldi B (editor). Practice of statistics in the life sciences, SPSS version. WH Freeman, 2008.
26. Wang TJ, Evans JC, Benjamin EJ, et al. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003 ; 108: 977-982
27. Wang TJ, Levy D, Benjamin EJ, et al. The epidemiology of 'asymptomatic' left ventricular systolic dysfunction: implications for screening. Ann Intern Med. 2003 ; 138: 907-916
28. Vasan RS, Larson MG, Benjamin EJ, et al. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 1997 ; 336: 1350-1355
29. Gardin JM, Siscovick D, Anton-Culver H, et al. Sex, age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The cardiovascular health study. Circulation. 1995 ; 91: 1739-1748
30. Mosterd A, de Bruijne MC, Hoes AW, et al. Usefulness of echocardiography in detecting left ventricular sytolic dysfunction (the Rotterdam study). Am J Cardiol. 1997 ; 79: 103-104
31. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community. Appreciating the scope of the heart failure epidemic. JAMA. 2003 ; 289: 194-201
32. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA. 2002 ; 288: 1252-1259
33. Davie AP, Love MP, McMurray II. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ. 1996 ; 312: 222-222
34. Rihal CS, Davis KB, Kennedy JW, et al. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol. 1995 ; 75: 220-223
35. Nielsen OW, Hansen JF, Hilden J, et al. Risk assessment of left ventricular systolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. BMJ. 2000 ; 320: 220-224
36. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA. 2002 ; 288: 1252-1259
37. Di Angelantonio E, Chowdhury R, et al. B-Type natriuretic peptides and cardiovascular risk. Circulation. 2009 ; 120: 2177-2187
38. Mureddu GF, Tarantini L, Agabiti N, et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and preclinical heart failure in the elderly. Result from 'PREDICTOR' a population based study in central Italy. Eur J Heart Fail 2013; 15: 1102-1112.
39. Atherton JJ. Screening for left ventricular systolic dysfunction: is imaging a solution?. J Am Coll Cardiol Img. 2010 ; 3: 421-428
40. Galasko GI, Barnes SC, Collinson P, et al. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?. Eur Heart J. 2006 ; 27: 193-200
41. Lindekleiv H, Lochen ML, Mathiesen EB, et al. Echocardiographic screening of the general population and long-term survival. A randomized clinical study. JAMA Intern Med 2013; 173: 1592-1598.
42. Coller JM, Campbell DJ, Krum H, et al. Early identification of asymptomatic subjects at increased risk of heart failure and cardiovascular events. Progress and future directions. Heart Lung Circ. 2013 ; 22: 171-178